Cellular reprogramming for pancreatic β‐cell regeneration: clinical potential of small molecule control
Abstract Recent scientific breakthroughs in stem cell biology suggest that a sustainable treatment approach to cure diabetes mellitus (DM) can be achieved in the near future. However, the transplantation complexities and the difficulty in obtaining the stem cells from adult cells of pancreas, liver,...
Main Authors: | Ganesh N Pandian, Junichi Taniguchi, Hiroshi Sugiyama |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2014-12-01
|
Series: | Clinical and Translational Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/2001-1326-3-6 |
Similar Items
-
Reprogramming cell fates by small molecules
by: Xiaojie Ma, et al.
Published: (2017-02-01) -
Implications of Cellular Aging in Cardiac Reprogramming
by: Fabiana Passaro, et al.
Published: (2018-04-01) -
Direct reprogramming of fibroblasts into cardiomyocytes
by: Yueqiu Chen, et al.
Published: (2017-05-01) -
How to reprogram human fibroblasts to neurons
by: Ziran Xu, et al.
Published: (2020-10-01) -
Reprogramming cells with synthetic proteins
by: Xiaoxiao Yang, et al.
Published: (2015-06-01)